Bacterial resistance in cirrhotic patients: An emerging reality

Journal of Hepatology

Volumn 56, Issue 4, 2012, Pages 756-757

  Merli, Manuela ^a   Lucidi, Cristina ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; CHRONIC DRUG ADMINISTRATION; DISEASE ASSOCIATION; EDITORIAL; HUMAN; INFECTION SENSITIVITY; LIVER CIRRHOSIS; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE;

CEFTRIAXONE; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INFECTIOUS DISEASE TRANSMISSION, PROFESSIONAL-TO-PATIENT; MALE; PERITONITIS;

EID: 84858699498     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2011.12.004     Document Type: Editorial

References (20)

1. H.E. Wasmuth, D. Kunz, E. Yagmur, A. Timmer-Stranghoner, D. Vidacek, and E. Siewert Patients with acute on chronic liver failure display ''sepsis-like'' immune paralysis J Hepatol 42 2005 195 201 (Pubitemid 40143465)
2. R. Wiest, and G. Garcia-Tsao Bacterial translocation (BT) in cirrhosis Hepatology 41 2005 422 433 (Pubitemid 40289486)
3. M. Cazzaniga, E. Dionigi, G. Gobbo, A. Fioretti, V. Monti, and F. Salerno The systemic inflammatory response syndrome in cirrhotic patients: relationship with their in-hospital outcome J Hepatol 51 2009 475 482
4. C. Trautwein, K. Boker, and M.P. Manns Hepatocyte and immune system: acute phase reaction as a contribution to early defence mechanism Gut 35 1994 1163 1166 (Pubitemid 24277324)
5. C. Gabay, and I. Kushner Acute-phase proteins and other systemic responses to inflammation N Engl J Med 340 1999 448 454 (Pubitemid 29084777)
6. T. Gustot, F. Durand, D. Lebrec, J.L. Vincent, and R. Moreau Severe sepsis in cirrhosis Hepatology 50 2009 2022 2033
7. V. Arvaniti, G. D'Amico, G. Fede, P. Manousou, E. Tsochatzis, and M. Pleguezuelo Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis Gastroenterology 139 2010 1246 1256
8. J. Fernández, M. Navasa, J. Gómez, J. Colmenero, J. Vila, and V. Arroyo Bacterial infection in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis Hepatology 35 2002 140 148 (Pubitemid 34032554)
9. N.D. Friedman, K.S. Kaye, J.E. Stout, S.A. McGarry, S.L. Trivette, and J.P. Briggs Health care associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections Ann Intern Med 137 2002 791 797 (Pubitemid 35334450)
10. M. Venditti, M. Falcone, S. Corrao, G. Licata, P. Serra Study Group of the Italian Society of Internal Medicine Outcomes of patients hospitalized with community-acquired, health care-associated, and hospital acquired pneumonia Ann Intern Med 150 2009 19 26
11. M. Merli, C. Lucidi, V. Giannelli, M. Giusto, O. Riggio, and M. Falcone Cirrhotic patients are at risk for health care-associated bacterial infections Clin Gastroenterol Hepatol 8 2010 979 985
12. B.A. Runyon Changing flora of bacterial infections in patients with cirrhosis Liver Int 30 2010 1245 1246
13. M.E. Falagas, P.K. Koletsi, and I.A. Bliziotis The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa J Med Microbiol 55 2006 1619 1629 (Pubitemid 44902023)
14. C. Lucidi, V. Giannelli, M. Giusto, A. Ruffa, B. Lattanzi, and O. Riggio High prevalence of MDR infections in cirrhotic patients who have had contact with the health care system Hepatology 54 2011 1236A
15. S. Fasolato, P. Angeli, L. Dallagnese, G. Maresio, E. Zola, and E. Mazza Renal failure and bacterial infection in patients with cirrhosis: epidemiology and clinical features Hepatology 45 2007 223 229 (Pubitemid 46144382)
16. European Association for the Study of the Liver. EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis. European Association for the Study of the Liver. J Hepatol 2010;53:397-417.
17. X. Ariza, J. Castellote, J. Lora-Tamayo, A. Girbau, S. Salord, and R. Rota Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis J Hepatol 56 2012 825 832
18. S. Angeloni, C. Leboffe, A. Parente, M. Venditti, A. Giordano, and M. Merli Efficacy of current guidelines for the treatment of spontaneous bacterial peritonitis in the clinical practice World J Gastroenterol 14 2008 2757 2762
19. H.S. Cheong, C. Kang, J.A. Lee, S.Y. Moon, M.K. Joung, and D.R. Chung Clinical significance and outcome of nosocomial acquisition of spontaneous bacterial peritonitis in patients with liver cirrhosis Clin Infect Dis 48 2009 1230 1236
20. A. Rimola, G. García-Tsao, M. Navasa, L.J. Piddock, R. Planas, and B. Bernard Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club J Hepatol 32 2000 142 153 (Pubitemid 30039459)